(AOF) – Nucera (+8.94% to 9.75 euros), the subsidiary of the German group Thyssenkrupp specializing in hydrogen, is progressing on the stock market after the announcement this Tuesday of favorable forecasts for the 2024/2025 financial year. “Thyssenkrupp Nucera’s long-term growth prospects remain intact. We have a strong financial foundation and are perfectly positioned to grow in the green hydrogen market with our technology, products and people,” said Werner Ponikwar, CEO of the group, alongside the presentation of the 2023/2024 annual results.
The Thyssenkrupp Nucera executive committee is targeting a turnover of between 850 and 950 million euros for the 2024/2025 financial year compared to 862 million euros for the 2023/2024 financial year.
In the green hydrogen segment, its sales should be between 450 and 550 million euros (compared to 524 million euros for the 2023/2024 financial year).
For the chlorine and soda segment, the group expects an increase in sales of between 380 and 420 million euros compared to an increase of 338 million euros over the last financial year. New facilities and service activities are expected to contribute to this growth.
Its sales for the 2023/2024 financial year increased by 30%. The main driver of sales is again the water electrolysis sector with its green hydrogen production technology. The turnover of the “AWE” activity increased by 60% to reach 524 million euros.
In the fourth quarter of 2023/2024, Thyssenkrupp Nucera improved its turnover by 50% to reach 250 million euros, “the highest quarterly turnover ever”.
Un Ebit en net repli
On the other hand, the company explains that “as expected, the increase in research and development costs and administrative costs linked to the implementation of its growth strategy led to a drop in Ebit which stood at -14 million euros. For the 2022/2023 financial year, the group posted an Ebit of 25 million euros.
In the last quarter of the 2023/2024 financial year, Ebit increased from 5 million euros to 3 million euros.
For the financial year 2024/2025, the Board of Directors expects EBIT to be between -30 million and 5 million euros. “The development of EBIT depends to a large extent on the execution and revenue recognition of the existing order book,” explains Thyssenkrupp Nucera.
In 2023/2024, the EBIT margin fell from 4 to 2%. Its net profit fell by 54% to 11 million euros. Earnings per share amounted to 0.09 euros compared to 0.22 a year ago.
During the 2023/2024 financial year, its order intake increased by 4% to reach 636 million euros.
